• SENSEX 76,632.24
    -122.81 (--0.16%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
Back

Results - Announcements

Sales decline 32.89% to Rs 3.06 crore

Ishita Drugs & Industries standalone net profit declines 37.93% in the March 2026 quarter
01-Jun-2026, 07:27
Net profit of Ishita Drugs & Industries declined 37.93% to Rs 0.18 crore in the quarter ended March 2026 as against Rs 0.29 crore during the previous quarter ended March 2025. Sales declined 32.89% to Rs 3.06 crore in the quarter ended March 2026 as against Rs 4.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 10.34% to Rs 0.78 crore in the year ended March 2026 as against Rs 0.87 crore during the previous year ended March 2025. Sales declined 2.27% to Rs 14.66 crore in the year ended March 2026 as against Rs 15.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.064.56 -33 14.6615.00 -2
OPM %3.276.36 -5.256.67 -
PBDT0.300.41 -27 1.181.27 -7
PBT0.280.38 -26 1.081.16 -7
NP0.180.29 -38 0.780.87 -10

Powered by Capital Market - Live News